vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
38.30
+2.09 (5.77%)
Mar 25, 2026, 4:00 PM EDT - Market closed
vTv Therapeutics Employees
vTv Therapeutics had 26 employees as of December 31, 2025. The number of employees increased by 3 or 13.04% compared to the previous year.
Employees
26
Change (1Y)
3
Growth (1Y)
13.04%
Revenue / Employee
n/a
Profits / Employee
-$1,037,462
Market Cap
150.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 26 | 3 | 13.04% |
| Dec 31, 2024 | 23 | 7 | 43.75% |
| Dec 31, 2023 | 16 | 3 | 23.08% |
| Dec 31, 2022 | 13 | 4 | 44.44% |
| Dec 31, 2021 | 9 | -16 | -64.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 316 |
| Codexis | 146 |
| Heron Therapeutics | 128 |
| Nkarta | 105 |
| Precision BioSciences | 68 |
| Corbus Pharmaceuticals Holdings | 36 |
| Unicycive Therapeutics | 23 |
| Sagimet Biosciences | 14 |
VTVT News
- 10 days ago - vTv Therapeutics to Participate in the 38th Annual ROTH Conference - GlobeNewsWire
- 15 days ago - vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 26 days ago - VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst - Seeking Alpha
- 5 weeks ago - vTv Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewsWire
- 3 months ago - vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - GlobeNewsWire
- 4 months ago - vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewsWire